Article Details

Revisiting Novartis versus Natco – Cancer drugs, divisional applications and patent validity

Retrieved on: 2024-12-17 14:32:07

Tags for this article:

Click the tags to see associated articles and topics

Revisiting Novartis versus Natco – Cancer drugs, divisional applications and patent validity. View article details on hiswai:

Excerpt

The court reaffirmed its prima facie finding that the suit patent satisfied the requirements of novelty and inventive step under the Patents Act.

Article found on: www.bananaip.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up